SCHEMBL15280430

SCHEMBL15280430

CC(=O)[C@@H]1Cc2ccccc2N1S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.67
ALDH1A1 P00352 5/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
NPSR1 Q6W5P4 2/20 0.47
ESR1 P03372 1/20 0.47
POLB P06746 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
USP2 O75604 2/20 0.44
APOBEC3A P31941 1/20 0.44
APOBEC3G Q9HC16 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GAA P10253 1/20 0.44
PTGER3 P43115 1/20 0.44
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
MMP2 P08253 1/20 0.44
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16450981 1.00 LMNA (0.67) LMNAALDH1A1SMN1; SMN2NPSR1ESR1
SCHEMBL16450976 1.00 LMNA (0.67) LMNAALDH1A1SMN1; SMN2NPSR1ESR1
SCHEMBL18041161 0.90 LMNA (0.67) LMNAALDH1A1SMN1; SMN2NPSR1ESR1
SCHEMBL15280427 0.90 LMNA (0.67) LMNAALDH1A1SMN1; SMN2NPSR1ESR1
SCHEMBL5569768 0.90 LMNA (0.67) LMNAALDH1A1SMN1; SMN2NPSR1ESR1
SCHEMBL15280428 0.90 LMNA (0.67) LMNAALDH1A1SMN1; SMN2NPSR1ESR1
SCHEMBL15280429 0.82 LMNA (0.58) LMNAALDH1A1SMN1; SMN2NPSR1ESR1
SCHEMBL8421007 0.81 LMNA (1.00) LMNAALDH1A1SMN1; SMN2NPSR1ESR1
SCHEMBL7786222 0.80 NOTUM (0.46) LMNAMEN1MAPTKMT2A
SCHEMBL28751377 0.79 LMNA (0.52) LMNAALDH1A1NPSR1ESR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266490-B2 Radioprotector compounds GEORGETOWN UNIVERSITY (US) 2019-04-23 US disclosed
US-20150044293-A1 RADIOPROTECTOR COMPOUNDS GEORGETOWN UNIVERSITY (US) 2015-02-12 US disclosed
US-20150044293-A1 RADIOPROTECTOR COMPOUNDS GEORGETOWN UNIVERSITY (US) 2015-02-12 US disclosed
WO-2013138600-A1 RADIOPROTECTOR COMPOUNDS ROSEN ELIOT M (US) 2013-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10266490-B2 Radioprotector compounds DDB1, CASP3, BAD LMNA 649/4885ALDH1A1 1017/4885SMN1; SMN2 4260/4885
US-20150044293-A1 RADIOPROTECTOR COMPOUNDS DDB1, CASP3, BAD LMNA 649/4885ALDH1A1 1017/4885SMN1; SMN2 4260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.